A growing number of European cannabis startups are considering initial public offerings in the United States, where they expect higher valuations in New York than on a London-based exchange.

But that’s only if the Biden administration’s ongoing efforts to reschedule marijuana are successful, according to the Financial Times and Euro News.

ADVERTISEMENT

U.S. law currently prohibits American plant-touching companies from listing on major American stock exchanges.

However, operators in Canada – where marijuana is legal at the federal level – such as Canopy Growth Corp. (CGC) and SNDL are permitted to list on the Nasdaq.

English, Portuguese companies interested

England-based medical cannabis operator Grow Group has raised 12 million pounds (roughly $15.6 million) since its 2017 inception, but the company declined to go public

Read full article on Marijuana Business Daily